GLOBOCAN 2022全球癌症统计数据解读

Interpretation on the global cancer statistics of GLOBOCAN 2022

2024年2月国际癌症研究机构(International Agency for Research on Cancer,IARC)发布了最新的全球癌症统计数据GLOBOCAN 2022,估计了全球185个国家/地区的36种癌症发病数/率、死亡数/率等最新数据,描述了不同国家/地区和性别下的癌症负担差异,并对至2050年的癌症负担进行了预测。GLOBOCAN 2022数据显示,2022年全球估计新发癌症19976499例,9743832例癌症患者死亡。肺癌是全球首位常见癌症,2022年发病例数为2480675例,占总体癌症发病的12.4%。其次是乳腺癌(11.5%)、结直肠癌(9.6%)、前列腺癌(7.3%)和胃癌(4.9%)。肺癌仍是导致癌症死亡的首要原因,估计有1817469例死亡,占总体癌症死亡的18.7%。其次是结直肠癌(9.3%)、肝癌(7.8%)、乳腺癌(6.8%)和胃癌(6.8%)。基于人口统计学的预测表明,到2050年,全球新增癌症病例将达到3528.1万例,与2022年相比增加76.6%。全球癌症发病和死亡具有明显的地区和性别差异。本文对更新的数据库中主要内容进行整理并加以解读。

In February 2024,International Agency for Research on Cancer(IARC)released the latest global cancer statistics,GLOBOCAN 2022,which estimated the latest data on the number/rates of incidence and deaths of 36 types of cancer in 185 countries/regions around the world,described differences in the burden of cancer by countries/regions and gender,and provided projections of the cancer burden up to 2050.The GLOBOCAN 2022 data showed that in 2022,there were an estimated 19976499 new cancer cases and 9743832 cancer deaths worldwide.Lung cancer was the most common cancer worldwide,with 2480675 cases in 2022,accounting for 12.4%of all cancer cases,followed by breast cancer(11.5%),colorectal cancer(9.6%),prostate cancer(7.3%)and stomach cancer(4.9%).Lung cancer remained the leading cause of cancer deaths,with an estimated 1817469 deaths,accounting for 18.7%of overall cancer deaths,followed by colorectal cancer(9.3%),liver cancer(7.8%),breast cancer(6.8%)and stomach cancer(6.8%).Demographicsbased projections indicate that by 2050,there will be 35.28 million new cancer cases globally,a 76.6% increase from 2022 levels.There are significant regional and gender differences in global cancer incidence and mortality.In this article,the main contents of the updated database are sorted out and interpreted.